XML 129 R117.htm IDEA: XBRL DOCUMENT v3.6.0.2
Share-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total compensation expense $ 7,508 $ 3,975 $ 9,647
Income tax benefits 2,458 1,143 2,404
Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total compensation expense 5,318 $ 2,320 6,263
Expense $ 6,403    
Weighted average period (years) 1 year 4 months 24 days    
Status of, and changes in, the Performance Share Unit Plan units granted to employees      
Outstanding at the beginning of the period (in shares) 440,089    
Granted (in shares) 313,837    
Forfeited (in shares) (3,158)    
Exercised (in shares) (151,857)    
Outstanding at the end of the period (in shares) 598,911 440,089  
Vested and expected to vest (in shares) 598,911    
Great West Lifeco Inc | Employee and Directors Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total compensation expense $ 2,190 $ 1,655 $ 3,384
Expense $ 2,684    
Weighted average period (years) 1 year 8 months 12 days    
Shares under option      
Outstanding at the beginning of the period (in shares) 3,633,343    
Granted (in shares) 973,100    
Exercised (in shares) (359,345)    
Cancelled and Expired (in shares) (185,097)    
Outstanding at the end of the period (in shares) 4,062,001 3,633,343  
Vested and expected to vest at the end of the period (in shares) 4,062,001    
Exercisable at the end of the period (in shares) 2,292,059    
Exercise price (Whole dollars)      
Outstanding at the beginning of the period (in dollars per share) $ 21.68    
Granted (in dollars per share) 25.88    
Exercised (in dollars per share) 20.03    
Cancelled and Expired (in dollars per share) 25.87    
Outstanding at the end of the period (in dollars per share) 23.25 $ 21.68  
Vested and expected to vest at the end of the period (in dollars per share) 23.25    
Exercisable at the end of the period (in dollars per share) $ 21.81    
Remaining contractual term      
Outstanding, December 31, 2016 6 years 1 month 6 days    
Vested and expected to vest, December 31, 2016 6 years 1 month 6 days    
Exercisable, December 31, 2016 4 years 3 months 18 days    
Aggregate intrinsic value      
Outstanding, December 31, 2016 [1] $ 12,814    
Vested and expected to vest, December 31, 2016 [1] 12,814    
Exercisable, December 31, 2016 [1] $ 10,654    
Other information      
Weighted average fair value of options granted (in dollars per share) $ 2.74 $ 3.33 $ 5.53
Intrinsic value of options exercised [2] $ 2,102 $ 4,234 $ 401
Fair value of options vested $ 1,605 $ 1,670 $ 4,491
Weighted-average assumptions      
Dividend yield 3.99% 3.66% 3.95%
Expected volatility 19.03% 19.10% 26.63%
Risk free interest rate 0.80% 0.90% 1.75%
Expected duration (years) 6 years 6 years 6 years
[1] The aggregate intrinsic value is calculated as the difference between the market price of Lifeco common shares on December 31, 2016, and the exercise price of the option (only if the result is positive) multiplied by the number of options.
[2] The intrinsic value of options exercised is calculated as the difference between the market price of Lifeco common shares on the date of exercise and the exercise price of the option multiplied by the number of options exercised.